The short version
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ampicillin Sodium · AMPICILLIN SODIUM 1 g/1 · Injection, Powder, For Solution · Intramuscular; Intravenous · ProPharma Distribution
NDC 84549-0113-10 · 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL · ANDA · View full market →
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 55150-0113-10) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| NorthStar Rx, LLC | AMPICILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Sep 3, 2026 |
| Sandoz Inc | AMPICILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 3, 2026 |
| Sandoz Inc | AMPICILLIN SODIUM 10 g/1 | Jul 15, 2026 | Sep 3, 2026 |
| Armas Pharmaceuticals Inc. | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Athenex Pharmaceutical Division, LLC. | AMPICILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy Inc. | AMPICILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Civica, Inc. | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | AMPICILLIN SODIUM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | AMPICILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | AMPICILLIN SODIUM 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | AMPICILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | AMPICILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | AMPICILLIN SODIUM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | AMPICILLIN SODIUM 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Henry Schein, Inc. | AMPICILLIN SODIUM 1 g/1 | Aug 5, 2026 | Sep 2, 2026 |
| Henry Schein, Inc. | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | AMPICILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx, LLC | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx, LLC | AMPICILLIN SODIUM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx, LLC | AMPICILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| ProPharma Distribution | AMPICILLIN SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | AMPICILLIN SODIUM 10 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | AMPICILLIN SODIUM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | AMPICILLIN SODIUM 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Aug 31, 2026 |
| Sandoz Inc | AMPICILLIN SODIUM 2 g/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Ampicillin — NDC 84549-0113-10," retrieved September 3, 2026, https://drugdashboards.com/drug/84549011310.
Free to cite with attribution — see how the data is put together.